Stockreport

Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit [Yahoo! Finance]

Chemomab Therapeutics Ltd. - American Depositary Shares  (CMMB) 
PDF It is based on the unique role of the soluble protein CCL24 in promoting fibrosis and inflammation, and has developed CM-101, a first-in-class dual activity monoclonal a [Read more]